 | ||||||
| "weight loss" | ||||||
| NEWS | ||||||
| Revenue Update on Insys Therapeutics Inc(NASDAQ:INSY) ... an approved second-line treatment of chemotherapy-induced nausea and vomiting (CINV) and anorexia associated with weight loss in patients with ...
| ||||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
| Send Feedback |
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.